Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | Concert Pharmaceuticals Inc | Equity | 206022105 | 364 | 108 | SH | DFND | 1 | 0 | 108 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 56 | 16627 | SH | DFND | 1 | 16627 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001533964-22-000006 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Virtu Financial LLC | 1533964 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 47 | 13927 | SH | DFND | 5 | 13927 | 0 | 0 | May 18th, 2022 01:12AM | May 18th, 2022 01:12AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR/A | 0001172661-22-001499 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Alyeska Investment Group, L.P. | 1453072 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 1847 | 548090 | SH | SOLE | 1 | 548090 | 0 | 0 | May 18th, 2022 01:11AM | May 18th, 2022 01:11AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR/A | 0001845536-22-000003 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Kensington Investment Counsel, LLC | 1845536 | CONCERT PHARMACEUTICALS INC COM | Stock | 206022105 | 259 | 76749 | SH | SOLE | 0 | 76749 | 0 | 0 | May 17th, 2022 01:59AM | May 17th, 2022 01:59AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 0 | 40 | SH | DFND | 5 | 40 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 716 | 212607 | SH | DFND | 03 | 0 | 212607 | 0 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 2677 | 794352 | SH | DFND | 01 | 0 | 794352 | 0 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001475597-22-000010 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | HRT FINANCIAL LP | 1475597 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 48 | 14470 | SH | DFND | 14470 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:cnce | nasdaq:cnce Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | CONCERT PHARMACEUTICALS INC | COM | 206022105 | 51 | 15200 | SH | Put | DFND | 2 | 0 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | Concert Pharmaceuticals | Health Care | Pharmaceuticals & Biotechnology |